Dr. Jacqueline Lui, President of Eagle IP Group, gave an in-house seminar titled “IP Due Diligence: The Key to Realistic Valuation of Technology in Transactions” at The Chamber of Hong Kong Listed Companies.
我們過去活動
Recommended Insights
2019 CHINA TOP 10 IP CASE: VALEO V. LUCAS, FUKE, & CHEN
2020年6月8日Every year in the spring The Supreme People’s Court of PRC announces its “Top 10 Intellectual Property (IP) cases” and “50 typical IP cases in Chinese courts” of the year. Although not having precedential weight, these cases serve as a reference and guide people's courts at all levels regarding their intellectual property trials. It’s always […]
閱讀更多 >
Major and Exciting Changes to China’s Patent Law [Fourth Amendment to China's Patent Law]
2019年2月20日Major changes are on the horizon for China’s Patent Law, which will see an overhaul in many areas as early as this year (2019). On January 4, 2019, the National People’s Congress in China published the latest draft of the Fourth Amendment to China’s Patent Law. Several draft amendments have been released for public comment […]
閱讀更多 >
Chinese Courts Cares More About Patent Quality Now (A Doctrine of Equivalents Story)
2022年12月13日There is no doubt that the drafting quality of a patent can be crucial in determining the success (or failure!) of the patent during litigation. However, due to various reasons, patents often fail to use the right drafting strategies that best protect the invention. Too often, inexperienced or unsophisticated patent drafters merely listen to an […]
閱讀更多 >
Compositions Limited by Use: A Cautionary Tale
2022年10月26日Section 4.2.3, Part II Chapter 10 of the CNIPA’s Examination Guidelines (“Guidelines”) stipulates that if the specification only discloses one property or use of a composition, the composition claim shall be drafted as a “composition limited by the function or the use”. Furthermore, it specifically states that “most pharmaceutical claims shall be drafted as claims […]
閱讀更多 >